Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.88 |
| ▸ | THRB | P10828 | 2/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decane SCHEMBL2401531 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Tridecane SCHEMBL2399921 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| SCHEMBL1018256 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Dodecane SCHEMBL2402308 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| SCHEMBL2401084 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Nonane SCHEMBL18816369 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Decane SCHEMBL2402324 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Decane SCHEMBL2399919 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| Pentadecane SCHEMBL2401072 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 | |
| SCHEMBL2401532 | 1.00 | TSHR (0.88) | TSHRTHRBDGKANAAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013032-B2 | Photopolymerizable dental composition with suppressed change in color tone by monomer | KABUSHIKI KAISHA SHOFU (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20090227699-A1 | Photopolymerizable dental composition with suppressed change in color tone by monomer | KABUSHIKI KAISHA SHOFU | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227699-A1 | Photopolymerizable dental composition with suppressed change in color tone by monomer | DNMT3A, TET1, DNMT1 | TSHR 2041/4885THRB 1370/4885DGKA 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.